Edward C Albini

CIK 1240014 · CFO AND SECRETARY · last filed 2025-05-19

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$171.2K

Companies

Total Filings

Lifetime Open-Market Net

-$165.5K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

NOVC price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
STRO	CFO AND SECRETARY	15,652	$10.94	$171.2K	$0	23	2025-05-19
Paratek Pharmaceuticals, Inc. (NOVC) Delisted	V.P., Chief Financial Officer	23,624	—	—	-$165.5K	9	2008-06-03

Recent Filings · Page 3 of 4

32 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2019-01-31	STRO	Grant (A)	—	$0	EDGAR
2018-10-01	STRO	Conv (C)	+1,688	$0	EDGAR
2018-09-27	STRO	Grant (A)	—	$0	EDGAR
2008-06-03	Paratek Pharmaceuticals, Inc. (NOVC) Delisted	Mixed	+8,606	-$14.8K	EDGAR
2008-01-10	Paratek Pharmaceuticals, Inc. (NOVC) Delisted	Mixed	+6,600	-$10.2K	EDGAR
2007-12-14	Paratek Pharmaceuticals, Inc. (NOVC) Delisted	Grant (A)	—	$0	EDGAR
2007-10-15	Paratek Pharmaceuticals, Inc. (NOVC) Delisted	Mixed	—	-$36.8K	EDGAR
2007-10-12	Paratek Pharmaceuticals, Inc. (NOVC) Delisted	Mixed	—	-$35.8K	EDGAR
2007-09-28	Paratek Pharmaceuticals, Inc. (NOVC) Delisted	Mixed	—	-$32.9K	EDGAR
2007-09-27	Paratek Pharmaceuticals, Inc. (NOVC) Delisted	Mixed	—	-$34.1K	EDGAR

Showing 21–30 of 32

Prev Page 3 of 4 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.